The Securities Commission of Quebec and Ontario has granted Liminal Biosciences Inc.’s application to cease being a reporting issuer in all Canadian jurisdictions where it is currently a reporting issuer. This decision was based on several factors: Liminal Biosciences is not an OTC reporting issuer under Regulation 51-105; its securities are owned by fewer than 15 securityholders in each Canadian jurisdiction and fewer than 51 worldwide; its securities are not traded on any public marketplace in Canada or elsewhere; and the company is not in default of securities legislation in any jurisdiction. The decision was made under the Securities Act, R.S.O. 1990, c. S.5, as am., s. 1(10)(a)(ii) and National Policy 11-206 Process for Cease to be a Reporting Issuer Applications.
